Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis

Journal of Biological Regulators and Homeostatic Agents

Volumn 22, Issue 1, 2008, Pages 57-61

  Riccio, A ^a   Postiglione, L ^a   La Dogana, P ^a   Spano A ^a   Marzocchella, C ^a   Tarantino, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Anti CCP antibodies; HCV related arthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTHRITIS; ARTICLE; BONE EROSION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FREQUENCY ANALYSIS; HEPATITIS C; HUMAN; JOINT RADIOGRAPHY; MALE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIBODIES, ANTINUCLEAR; ARTHRITIS; ARTHRITIS, PSORIATIC; HEPATITIS C; HUMANS; JOINTS; PEPTIDES, CYCLIC; RETROSPECTIVE STUDIES;

HEPATITIS C VIRUS;

EID: 42549092130     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sawada T, Hirohata S, Inoue T, Ito K. Development arthritis after hepatitis C virus infection. Arthritis Rheum 1991; 34:1620-1.
2. Ueno Y, Kinoshita R, Kishimoto I, Okamoto S. Polyarthritis associated with Hepatitis C virus infection. Br J Rheumatol 1994; 33:289-1.
3. Lovy M, Starkebaum G, Uberoi S. Hepatitis C infection and rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 1996; 23:979-83.
4. Buskila D. Hepatitis C-associated arthritis. Curr Opin Rheumatol. 2000; 12:295-9.
5. Loustaud-Ratti V, Lunel F. Extrahepatic manifestations of hepatitis C virus infection. Rev Prat 2000; 15:1089-93.
6. Pyrsopoulos NT, Reddy KR. Extrahepatic manifestations of chronic viral hepatitis. Curr Gastroenterol Rep 2001; 3:71-8.
7. Rivera J, García-Monforte A, Pineda A, Millán Núñez-Cortés J. Arthritis in patients with chronic hepatitis C virus infection. J Rheumatol 1999; 26: 420-4.
8. Zuckerman E, Yeshurun D, Rosner I. Management of hepatitis C virus-related arthritis. Biodrugs 2001; 15:573-84.
9. Meyer zum Buschenfelde KH, Lohse AW, Gerken G. The role of autoimmunity in hepatitis C infection. J Hepatology 1995; 22:93-6.
10. Bogdanos DP, Mieli-Vergani G, Vergani D. Virus, liver and autoimmunity. Dig Liver Dis 2000; 32:440-6.
11. Baeten D, Peene I, Union A et al. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to fillagrin antibodies. Arthritis Rheum 2001; 44:2255-62.
12. Suzuki K, Sawada T, Murakami A et al. High diagnostic performance of Elisa detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 2003; 32:197-204.
13. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 2001;47: 1089-93. Erratum in: Clin Chem 2001; 47:1748.
14. Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101:273-81.
15. Masson-Bessiere C, Sebbag M, Durieux JJ et al. In the rheumatoid pannus, antifillagrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000; 119:544-52.
16. van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002; 4:87-93.
17. Schellekens GA, Visser H. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43:155-63.
18. Sene D, Ghillani-Dalbin P, Limal N et al. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome. Ann Rheum Dis 2006; 65:394-7.
19. Vannini A, Cheung K, Fusconi M et al. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis 2007; 66:511-6.
20. Bogdanos DP, Lenzi M, Okamoto M et al. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int J Immunopathol Pharmacol 2004; 17: 83-92.